SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sandström Karl 1973 )
 

Sökning: WFRF:(Sandström Karl 1973 ) > (2020-2024) > Serum Proteomics in...

Serum Proteomics in Patients with Head and Neck Cancer : Peripheral Blood Immune Response to Treatment

Astradsson, Thorsteinn (författare)
Uppsala universitet,Öron-, näs- och halssjukdomar
Sellberg, Felix (författare)
Uppsala universitet,Klinisk immunologi
Ehrsson, Ylva Tiblom (författare)
Uppsala universitet,Vårdvetenskap,Öron-, näs- och halssjukdomar
visa fler...
Sandström, Karl, 1973- (författare)
Uppsala universitet,Öron-, näs- och halssjukdomar
Laurell, Göran (författare)
Uppsala universitet,Öron-, näs- och halssjukdomar
visa färre...
 (creator_code:org_t)
2022-06-04
2022
Engelska.
Ingår i: International Journal of Molecular Sciences. - : MDPI. - 1661-6596 .- 1422-0067. ; 23:11
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • In this real-world study, the aims were to prospectively evaluate the expression of inflammatory proteins in serum collected from head and neck cancer patients before and after treatment, and to assess whether there were differences in expression associated with treatment modalities. The mixed study cohort consisted of 180 patients with head and neck cancer. The most common tumor sites were the oropharynx (n = 81), the oral cavity (n = 53), and the larynx (n = 22). Blood tests for proteomics analysis were carried out before treatment, 7 weeks after the start of treatment, and 3 and 12 months after the termination of treatment. Sera were analyzed for 83 proteins using an immuno-oncology biomarker panel (Olink, Uppsala, Sweden). Patients were divided into four treatment groups: surgery alone (Surg group, n = 24), radiotherapy with or without surgery (RT group, n = 94), radiotherapy with concomitant cisplatin (CRT group, n = 47), and radiotherapy with concomitant targeted therapy (RT Cetux group, n = 15). For the overall cohort, the expression levels of 15 of the 83 proteins changed significantly between the pretreatment sample and the sample taken 7 weeks after the start of treatment. At 7 weeks after the start of treatment, 13 proteins showed lower expression in the CRT group compared to the RT group. The majority of the inflammatory proteins had returned to their pretreatment levels after 12 months. It was clearly demonstrated that cisplatin-based chemoradiation has immunological effects in patients with head and neck cancer. This analysis draws attention to several inflammatory proteins that are of interest for further studies.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

cytokines
protein expression
chemoradiotherapy
oropharyngeal cancer
cisplatin

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy